Cargando…
Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series
Purpose To assess whether transcutaneous retrobulbar Amphotericin B (TRAMB) injection can halt disease progression and reduce the requirement of exenteration in post-COVID 19 Rhino-orbital cerebral Mucormycosis (ROCM)) with limited orbital disease. Methods Retrospective series from a single center i...
Autores principales: | Pathak, Madhumallika, Sahu, Vijaya, Arora, Ripu Daman, Shambharkar, Martina M., Naveen, Prithvi, Pati, Saroj Kumar, Nagarkar, Nitin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547996/ https://www.ncbi.nlm.nih.gov/pubmed/36246726 http://dx.doi.org/10.1007/s12070-022-03199-7 |
Ejemplares similares
-
Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India
por: Nagarkar, Nitin M., et al.
Publicado: (2023) -
Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B
por: Safi, Mustafa, et al.
Publicado: (2020) -
Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
por: Murthy, Ramesh, et al.
Publicado: (2022) -
Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
por: Singh, Prabhakar, et al.
Publicado: (2022) -
Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19
por: Shakrawal, Jyoti, et al.
Publicado: (2022)